Great read.
Deflating the 2 billion statistic, then, reinforces that “this is one of the world’s nastiest pathogens, not some symbiont that we live with in peace”
Wise words from Dr. Behr
A small group of researchers is on a years-long crusade to set the record straight on one of tuberculosis's most persistent myths.
@KatherineJWu reports: https://t.co/lZV2Gx4olF
An honour to collaborate on this review on the growing anti-mycobacterial pipeline https://t.co/x48AvxYvhU with a true expert in mycobacterial pharmacology, Dr. S. Field. Published in @DrugsJournal#tuberculosis#TB@UCalgaryMed@UCalgary
Pleased to share our work on this utilizable biomarker in M. avium PD: Time to Positive Culture Detection Predicts Mycobacterium avium Pulmonary Disease Severity and Treatment Initiation | Annals of the American Thoracic Society | Articles in Press https://t.co/fNkShpIqw4
Resistance to bedaquiline in TB ... unfortunately an emerging problem with wider use in South Africa. Supporting adherence and treatment completion, and ensuring its use in effective regimens are key to prevention.
https://t.co/WsSkpEp4b7
@angie_rasmussen Expertise combined with sound available evidence, experience, and rationality. This is incredibly helpful. Thanks for taking the time to put it together.